Author

H. R. Kim

OpenAlex ID: A5035397486

Osimertinib or platinum–pemetrexed in EGFR T790M–positive lung cancer

2017 · Tony Mok, Yi‐Long Wu, et al. · QUT ePrints (Queensland University of Technology) · 466

Brigatinib vs crizotinib in the phase 3 ALTA-1L trial: Updated results

2020 · Frank Griesinger, H. R. Kim, et al.

Works count: 2

Citation count: 466

H-index: 1

I10-index: 1